For best experience please turn on javascript and use a modern browser!
You are using a browser that is no longer supported by Microsoft. Please upgrade your browser. The site may not present itself correctly if you continue browsing.

The fact that a certain subset of patients with brain injury can benefit from the drug zolpidem, a GABA receptor agonist, is in itself not new. What is new is that the researchers in this study, led by the Amsterdam UMC, have found clues for the thus far unknown working mechanism behind this phenomenon. This could potentially help to find a more long-term solution for these patients. At the moment, using the sleeping drug only restores these patient’s brain functions for a short period of time.

Dampening hyperactivity

Using electroencephalography and magnetoencephalography the scientists show that cognitive deficits, speech loss, and motor impairments after severe brain injury are associated with stronger beta band connectivity throughout the brain. Neurological recovery after zolpidem occurs with the restoration of beta band connectivity. Or, as first author Hisse Arnts of the Amsterdam UMC explained it to the media in more simple terms: the brain scans of the patients showed hyperactivity in specific parts of the brain. This hyperactivity overshadows the normal brain activity. The sleeping drug dampens the hyperactivity, thus restoring normal brain function.   


Among the media that covered this story is Dutch national news agency NOS. They have an item on their website that includes footage of the now 38-year old patient, Richard, who can once again talk with the help of the sleeping drug. 

Publication details

Hisse Arnts et al, Awakening after a sleeping pill: Restoring functional brain networks after severe brain injury, in: Cortex, November 2020,